Last Round
Private Equity
Apr 14, 2026
Est. Valuation
$777.3M
Total Funding Raised
$138M
Company Overview
Galea Therapeutics is a biotechnology company that develops small molecule drugs for the treatment of fatty liver disease and related metabolic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biotechnologydrug discoverysmall-molecule therapeuticsfatty liver diseasenon-alcoholic steatohepatitisNASHalcoholic steatohepatitisASHalcohol use disorderAUDmetabolic liver diseasebiotech startuppreclinical researchdrug pipelinepharma licensing
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Galea Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Galea Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Apr 14, 2026 | ||||
| IPO Announced | Nov 6, 2019 | ||||
| Series C | Sep 19, 2018 | ||||
| Series B | Nov 28, 2016 | ||||
| Series A | Dec 11, 2012 | ||||
Series 1 | Jun 15, 2010 |
Galea Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Private Equity |
| Balyasny Asset Management L.P. | Private Equity |
| RA Capital Management | Series C, Private Equity |
| Eventide Funds | Private Equity |
| Nan Fung Life Sciences | Series C |
| Deep Track Capital | Private Equity |
| Novo Ventures | Series C, Series B |
Galea Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Galea Therapeutics's valuation, stock price, and market status.